Philips Foundation: 44 Projects Supported and €31.2M Mobilized in 2025
The foundation of the Dutch health technology giant released its 2025 annual report on Tuesday, documenting a hybrid funding model combining grants and impact investments to enhance access to healthcare in underprivileged communities.
A Model Focused on Cardiovascular and Maternal Health
In 2025, the Philips Foundation adopted a catalytic philanthropy approach targeting two areas: cardiovascular diseases and maternal and child health. This focus aims to strengthen primary care, referral pathways between institutions, and the overall resilience of health systems in disadvantaged regions. The report highlights that this strategic positioning on two axes allows for the concentration of resources and amplifies the effects of the interventions.
44 Projects and 14 Impact Investments Mobilized
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
By the end of 2025, the foundation supported 44 active projects funded by grants, while managing a portfolio of 14 impact investments. This structure enabled the mobilization of €31.2M in external co-investments, thus expanding the financial leverage beyond its own funds. The report indicates that this combination of donations and profitable investments is at the heart of the catalytic model: grants fund high-risk social innovations, while impact investments generate revenues that are reinvested in new projects.
Gradual Progress Towards 100 Million Annual Beneficiaries
Providing care to 69 million people in 2025 brings the Philips Foundation closer to its long-term ambition: reaching 100 million beneficiaries per year. The report describes this trajectory as a progression resulting from scaling proven models, rather than multiplying small experimental projects.
SectorDispositifs médicaux et optique›Dispositifs médicaux
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: T3 2026
Key reported figures
Revenue: 4 393 millions d'euros
Quarterly revenue: 4 393 millions d'euros
Revenue growth: 2 %
Net income: 27 millions d'euros
Free cash flow: 384 millions d'euros
5 387 millions d'euros
Guidance from the release
« Our year-to-date results, together with our strong order book, give us confidence in delivering our full-year outlook and achieving our medium-term ambitions. » ; « Philips reiterates its full-year 2026 outlook »
Risks mentioned
Macro-economic and geopolitical changes including war in Ukraine and Middle East tensions, plus enacted and proposed tariffs and trade actions
Respironics-related legal proceedings and ongoing investigation by US State Attorneys General excluded from 2026 outlook
Phasing of Ultrasound sales and lower sales in China as previously communicated at Q2
Opportunities identified
Strong demand for latest AI-enabled innovations including new CT platforms Verida and Rembra, ultrasound system Alturion, and HealthSuite Imaging cloud solution
Accelerating innovation in image-guided therapy with EUR 50 million investment in AI, robotics and advanced imaging in Netherlands, plus EUR 150 million in private financing
Extended monitoring partnership with largest US health system through 2034 and expansion of Capsule platform, plus strategic partnerships in China and Latin America
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
